EGFR & ALK Inhibitors for Mutated Lung Cancer Tumors
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Miguel A. Villalona-Calero, MD, FACP, FAAAS
Date of Release
May 14th, 2025
